OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites
Diana Navas-Carrillo, José Miguel Rivera‐Caravaca, Arturo Sampedro-Andrada, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 58, Iss. 3, pp. 167-179
Closed Access | Times Cited: 14

Showing 14 citing articles:

Covalent organic frameworks (COFs)-based biosensors for the assay of disease biomarkers with clinical applications
Lin Wang, Haojie Xie, Yuxin Lin, et al.
Biosensors and Bioelectronics (2022) Vol. 217, pp. 114668-114668
Closed Access | Times Cited: 74

Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study
Shengnan Wang, Jianxin Xi, Mengyuan Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139394-139394
Closed Access | Times Cited: 1

Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done
Päivi Lakkisto, Louise T. Dalgaard, Thalía Belmonte, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 60, Iss. 2, pp. 141-152
Open Access | Times Cited: 23

Covalent organic frameworks (COFs) as carrier for improved drug delivery and biosensing applications
Rida Younas, Farhat Jubeen, N. Bano, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 7, pp. 2017-2049
Closed Access | Times Cited: 5

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches
Pierluigi Reveglia, Carmela Paolillo, Gabriella Ferretti, et al.
Metabolomics (2021) Vol. 17, Iss. 9
Open Access | Times Cited: 29

Epigenetic modifications in spinal ligament aging
Qian Xiang, Yongzhao Zhao, Jialiang Lin, et al.
Ageing Research Reviews (2022) Vol. 77, pp. 101598-101598
Open Access | Times Cited: 19

Gut microbiota and microRNAs as biomarkers in Parkinson’s disease: early identification, diagnostic and potential treatments
Javier Hernández-García, Patricia Muro-Reche, Esteban Orenes‐Piñero
Molecular and Cellular Biochemistry (2025)
Closed Access

What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer’s Disease?
Jinyue Zhou, Xiaoli Sun, Keren Wang, et al.
Neuroscience Bulletin (2025)
Closed Access

A review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis
Lingyu Liu, Shen Sun, Wenjie Kang, et al.
Reviews in the Neurosciences (2023) Vol. 35, Iss. 2, pp. 121-139
Closed Access | Times Cited: 8

Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology
Sharanjot Kaur, Harkomal Verma, Sukhchain Kaur, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 1, pp. 217-237
Closed Access | Times Cited: 7

The Biomarkers in Extreme Longevity: Insights Gained from Metabolomics and Proteomics
Xin Qiu, Yuangang Lu, Chao Mu, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 14, pp. 2725-2744
Open Access | Times Cited: 2

Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis
Khushboo Faldu, Jigna Shah
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 7, pp. 681-703
Closed Access | Times Cited: 6

Gender differences contribute to variability of serum lipid biomarkers for Alzheimer's disease
Jie Kawakami, Stephen Piccolo, John S. K. Kauwe, et al.
Biomarkers in Medicine (2022) Vol. 16, Iss. 15, pp. 1089-1100
Closed Access

Page 1

Scroll to top